Average Co-Inventor Count = 3.57
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. New York Blood Center, Inc. (11 from 193 patents)
2. The United States of America, As Represented by the Secretary, Department of Health and Human Services (6 from 3,539 patents)
11 patents:
1. 11571409 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
2. 11059808 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
3. 10869856 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
4. 10576059 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
5. 10413527 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
6. 10137107 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
7. 9309237 - HIV inhibitors
8. 8933019 - Antiviral cell-penetrating peptides
9. 8546439 - Small molecule inhibitors of retroviral assembly and maturation
10. 8324153 - Antiviral cell-penetrating peptides
11. 8299093 - Small molecule inhibitors of retroviral assembly and maturation